About
TCR-T cells
Areas of Focus
Categories
Biologics & BiopharmaceuticalStem Cell & Cellular TherapyChina
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
0
As Collaborator
3
Total Enrollment
27
By Phase
PHASE1: 3
By Status
RECRUITING: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06484556Collaborator
T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
PHASE1Recruiting
9 participants
Started: Jun 19, 2024 · Completed: Jun 30, 2027
NCT06484790Collaborator
T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
PHASE1Recruiting
9 participants
Started: Apr 8, 2024 · Completed: Apr 7, 2027
NCT06478251Collaborator
T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
PHASE1Recruiting
9 participants
Started: Feb 1, 2024 · Completed: Jun 30, 2027
Locations (1)
Headquarters
Suzhou, China
Map
Loading map...